Crescent Biopharma, Inc. · NASDAQ:CBIO

Pinkas Jan sold 658 Crescent Biopharma, Inc. shares (Form 4)

Traded Sep 16, 2026 · Filed Sep 18, 2026

On Sep 16, 2026, Pinkas Jan (Chief Scientific Officer) sold 658 Crescent Biopharma, Inc. shares at US$17.90 for US$11,778 under a trading plan, leaving 21,581 shares. Filed Sep 18, 2026 (Form 4).

Sold
658 shares
Price
US$17.90
Value
US$11,778
Holding after
21,581 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Scientific Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 16, 2026Ordinary SharesSale658US$17.9021,581Direct

Source

View original at SEC

Related